Signal active
Bio
As an Analyst on the Private Transactions team, Elise provides extensive research and analysis on individual companies operating in the healthcare industry in both the US and Europe.
Prior to joining Deerfield in 2010, Elise began her career in healthcare in 1987 as a venture capitalist and banker at PaineWebber Inc. and was an officer of PaineWebber Development Corporation, which managed nearly $1.0 billion in assets representing three PaineWebber funds and several research and development limited partnerships (RDLPs) invested in biotechnology and high technology companies. From 1996 to 2007, Elise was a Senior Research Analyst and Managing Director in healthcare primarily covering the biotechnology industry at PaineWebber Inc. (1996-2001) and Citigroup (2001-2007).
She holds an A.B. in Engineering Sciences with a specialty in Biomechanics from Harvard University and an M.B.A. from Harvard Business School.
Location
New York, New York, United States, North America
Social
Primary Organization
1994
271
143
128
101-250
Financial Services, Venture Capital, Impact Investing, Hedge Funds
Jobs history
1
HilleVax
Board Member
2021 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Elise Wang is the Partner, Head of Private Equity Capital Markets at Deerfield, based in New York, New York, United States, North America. With a background in Financial Services, Elise Wang has a rich history of leadership and innovation. Elise Wang studied unknown unknown @ Harvard Business School. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
4
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Aug 13, 2018 | Orchard Therapeutics | Series C - Orchard Therapeutics | - | 150.0M |
Jan 07, 2021 | Werewolf Therapeutics | Series B - Werewolf Therapeutics | Deerfield | 72.0M |
Sep 08, 2021 | HilleVax | Venture Round - HilleVax | Deerfield | 135.0M |
Jun 05, 2024 | Advanced Medicine Partners | Series A - Advanced Medicine Partners | Deerfield | 32.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.